Drug Shortage Report for MAVIK
| Report ID | 265063 |
| Drug Identification Number | 02231459 |
| Brand name | MAVIK |
| Common or Proper name | TRANDOLAPRIL |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TRANDOLAPRIL |
| Strength(s) | 1MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 BT |
| ATC code | C09AA |
| ATC description | ACE INHIBITORS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-09-03 |
| Actual start date | 2025-08-21 |
| Estimated end date | Unknown |
| Actual end date | 2025-10-10 |
| Shortage status | Resolved |
| Updated date | 2025-10-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-10-15 | French | Compare |
| v6 | 2025-10-15 | English | Compare |
| v5 | 2025-09-09 | French | Compare |
| v4 | 2025-09-09 | English | Compare |
| v3 | 2025-09-04 | English | Compare |
| v2 | 2025-08-12 | French | Compare |
| v1 | 2025-08-12 | English | Compare |
Showing 1 to 7 of 7